Effect of lithium on prostaglandin F1-stimulated adenylate cyclase activity of human platelets.
D000255:Adenosine Triphosphate / Q000032:analysis; D000262:Adenylyl Cyclases / Q000097:blood*; D001792:Blood Platelets / Q000201:enzymology*; D001798:Blood Proteins / Q000032:analysis; D002250:Carbon Radioisotopes; D002712:Chlorides / Q000494:pharmacology; D000242:Cyclic AMP / Q000096:biosynthesis; D004305:Dose-Response Relationship, Drug; D004789:Enzyme Activation / Q000187:drug effects; D004837:Epinephrine / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007700:Kinetics; D008094:Lithium / Q000494:pharmacology*; D008274:Magnesium / Q000494:pharmacology; D008566:Membranes / Q000201:enzymology; D009638:Norepinephrine / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology*; D012413:Rubidium / Q000494:pharmacology; D012964:Sodium / Q000494:pharmacology; D013268:Stimulation, Chemical; D014316:Tritium
D001798:Blood Proteins; D002250:Carbon Radioisotopes; D002712:Chlorides; D011453:Prostaglandins; D014316:Tritium; D000255:Adenosine Triphosphate; D008094:Lithium; D012964:Sodium; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D008274:Magnesium; D012413:Rubidium; D011188:Potassium; D009638:Norepinephrine; D004837:Epinephrine